17-hydroxyprogesterone levels are not helpful in the prediction of HCG timing in in vitro fertilization cycles.
Smith
K E
KE
Center for Advanced Reproductive Care, Redondo Beach, California 90277, USA.
Garzo
G
G
Hamilton
F
F
Meldrum
D R
DR
D019326:17-alpha-Hydroxyprogesterone / Q000097:blood*; D000328:Adult; D015415:Biomarkers; D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004624:Embryo Transfer; D004967:Estrogens / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage / Q000627:therapeutic use; D008596:Menotropins / Q000008:administration & dosage / Q000627:therapeutic use; D006080:Ovarian Follicle / Q000502:physiology; D011247:Pregnancy; D018873:Pregnancy Rate; D011374:Progesterone / Q000097:blood; D015203:Reproducibility of Results; D016896:Treatment Outcome
D015415:Biomarkers; D006063:Chorionic Gonadotropin; D004967:Estrogens; D011374:Progesterone; D008596:Menotropins; D019326:17-alpha-Hydroxyprogesterone; D016729:Leuprolide